CVSA Covista Inc.companySEC Filings & Insider Trading Activity 2026
Latest Covista Inc. (CVSA) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on August 7, 2025, a 10-Q quarterly report filed on January 28, 2026, an 8-K current report filed on April 9, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Covista Inc. (CVSA) (SEC CIK 730464), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-06-30)
Business Overview
- • Core business: Provider of postsecondary education with focus on medical and healthcare programs
- • Emphasis on regulatory compliance risks impacting Title IV funding and clinical placement limitations for medical schools
Risk Factors
- • Regulatory risk from U.S. Department of Education (ED) Borrower Defense to Repayment rules affecting Title IV loan obligations recovery
- • Geopolitical exposure to U.S. federal and state investigations, risking Title IV program eligibility restrictions across multiple institutions
Management Discussion & Analysis
- • No revenue or profit figures disclosed in the MD&A section
- • Key risk: potential fines, debt discharge liabilities, or suspension from Title IV programs due to "substantial misrepresentation" claims
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-12-31)
Risk Factors
- • New risk: Strategic advisory costs increased to $9.8M YTD 2025 from $0 in 2024, driven by market capacity expansion initiatives
- • Updated risk: Litigation reserve shifted from $(5.55)M in 2024 to $0 in 2025, reflecting new or ongoing legal matters impacting expenses
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 1.01: Entry into a Material Definitive Agreement
- • Signature block only — no deal terms, counterparty, financial obligations, or agreement details disclosed in this filing text
- • Signed by CFO Robert J. Phelan on March 3, 2026 — actual Item 1.01 material agreement content absent or filed separately
Item 2.03: Creation of a Direct Financial Obligation
- • Covista's Item 2.03 disclosure is incomplete — no financial obligation details provided in the filing text
- • Investors should review the full 8-K exhibit or amendment for borrowing terms, amount, interest rate, and maturity
Item 1.02: Termination of a Material Definitive Agreement
- • Full redemption of ~$404,950,000 in Notes at par (100% of principal) plus accrued interest, effective March 2, 2026
- • Indenture fully discharged — company and subsidiary guarantors have zero remaining obligations under this debt
Item 7.01: Regulation FD Disclosure
- • Reg FD disclosure contains only boilerplate forward-looking statement disclaimers — no operational data, guidance, or material business update disclosed
- • References future growth expectations but provides zero quantitative targets or specific strategic information
Annual Reports Archive10-K
AI-powered analysis of Covista Inc. (CVSA) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Covista Inc. (CVSA) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Covista Inc. (CVSA) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $1.4B | $1.5B | $1.6B | $1.8B |
| Operating Income | $80.5M | $168.2M | $217.1M | $341.5M |
| Net Income | $317.7M | $93.4M | $136.8M | $237.1M |
| Op. Margin | 5.8% | 11.6% | 13.7% | 19.1% |
| Net Margin | 22.9% | 6.4% | 8.6% | 13.3% |
| Balance Sheet | ||||
| Total Assets | $2.8B | $2.8B | $2.7B | $2.8B |
| Equity | $1.5B | $1.5B | $1.4B | $1.4B |
| ROE | 21.1% | 6.4% | 10.0% | 16.5% |
Source: XBRL financial data from Covista Inc. (CVSA) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 9, 2026 | — | — | — |
8-K | Mar 3, 2026 | — | Analysis | — |
8-K | Feb 24, 2026 | — | Analysis | — |
8-K | Feb 6, 2026 | — | — | |
10-Q | Jan 28, 2026 | Dec 31, 2025 | Analysis | |
8-K | Jan 28, 2026 | — | — | |
8-K | Dec 15, 2025 | — | — | |
10-Q | Oct 30, 2025 | Sep 30, 2025 | — | |
10-K | Aug 7, 2025 | Jun 30, 2025 | Analysis | |
10-Q | May 8, 2025 | Mar 31, 2025 | — | |
10-Q | Jan 30, 2025 | Dec 31, 2024 | — | |
10-Q | Oct 29, 2024 | Sep 30, 2024 | — | |
10-K | Aug 6, 2024 | Jun 30, 2024 | — | |
10-Q | May 2, 2024 | Mar 31, 2024 | — | |
10-Q | Jan 30, 2024 | Dec 31, 2023 | — | |
10-Q | Oct 26, 2023 | Sep 30, 2023 | — | |
10-K | Aug 10, 2023 | Jun 30, 2023 | — | |
10-Q | May 2, 2023 | Mar 31, 2023 | — | |
10-Q | Feb 2, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | — | |
10-K | Aug 11, 2022 | Jun 30, 2022 | — | |
10-Q | May 5, 2022 | Mar 31, 2022 | — | |
10-Q | Feb 8, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 3, 2021 | Sep 30, 2021 | — | |
10-K | Aug 19, 2021 | Jun 30, 2021 | — |
Frequently Asked Questions
What are the latest CVSA SEC filings in 2026?
Covista Inc. (CVSA) has filed a 10-K annual report on August 7, 2025, a 10-Q quarterly report on January 28, 2026, an 8-K current report on April 9, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CVSA file its most recent 10-K annual report?
Covista Inc. (CVSA) filed its most recent 10-K annual report on August 7, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CVSA 10-Q quarterly reports?
Covista Inc. (CVSA)'s most recent 10-Q quarterly report was filed on January 28, 2026. SignalX displays every CVSA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CVSA filed recently?
Covista Inc. (CVSA)'s most recent 8-K was filed on April 9, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CVSA insider trading activity (Form 4)?
SignalX aggregates every CVSA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CVSA file with the SEC?
Covista Inc. (CVSA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CVSA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Covista Inc. (CVSA).
What is CVSA's SEC CIK number?
Covista Inc. (CVSA)'s SEC CIK (Central Index Key) number is 730464. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 730464 to look up all CVSA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find CVSA return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Covista Inc. (CVSA) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Covista Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 45+ filings.